therapies which will significantly expand the role of vaccines in public health.
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In the case of Salmonella vaccines, attenuation of wildtype strains has focused both on 
110
the cytoplasm essential for bacterial intracellular survival and replication [6] .
111
In a study reported by Hindle et al. [7] , attenuated vaccine candidates from both S. 
138
which we illustrate schematically in Figure 1 . Fully virulent strains, as well as vaccine
139
candidates, which are insufficiently attenuated elicit unacceptable clinical symptoms (i.e. highly 140 reactogenic) but also tend to be highly immunogenic ( Figure 1A) . Vaccines that have been
141
genetically engineered to minimize reactogenicity may become insufficiently immunogenic
142
( Figure 1B) . Ideally, the most promising live vaccines that perform well in clinical trials will 143 achieve a delicate balance between reactogenicity and immunogenicity ( Figure 1C) .
144
This concept is clearly illustrated by a series of attenuated S. Typhi candidate oral
145
vaccines engineered from the wildtype strain CDC10-80, all carrying a deletion in the aroA gene
146
critical to the aromatic amino acid biosynthesis pathway. When coupled with an additional 147 mutation in aroD, the resulting aroA aroD strain proved to be insufficiently attenuated but
148
highly immunogenic ( Figure 1A ) [10] . When the triple deletion mutant aroA aroD htrA was 149 constructed (by further deletion of htrA encoding a heat-shock serine protease), safety improved
150
at lower oral dosage levels but immunogenicity declined ( Figure 1B) ; at higher oral doses which 151 improved immunogenicity, reactogenicity (i.e. fever and bacteremia) was unacceptably high
152
( Figure 1A ) [10] . 
212
37°C, the resulting strains were highly attenuated yet immunogenic when this mutation was coupled with a metabolic deletion in a sugar utilization pathway. to be controlled by the arabinose activator/repressor AraC [23] . In the presence of arabinose, low-copy-number SSB-stabilized plasmids carried by less attenuated carrier vaccines [35] .
348
Minimizing metabolic stress by synchronizing antigen expression with metabolism.
349
Success with plasmid maintenance systems that essentially guarantee plasmid stability in vivo
350
can quickly lead to additional problems with over-attenuation frequently associated with
351
plasmid-based delivery of foreign proteins. Due to the multicopy aspect of plasmids, when
352
foreign genes are induced there is a rapid rise in antigen synthesis (Figure 2A ) [36] Figure 2B ) [43] , and was created by engineering 365 modifications to the well characterized lactose repressor (LacI) transcriptional control system 366 frequently employed to control foreign antigen synthesis [44] . In the absence of lactose or other 
382
A thorough characterization of plasmid-based regulated delayed antigen synthesis in 383 attenuated S. Typhimurium carrier vaccines was described by Wang et al. [43] 
441
Antigen delivery by regulated lysis. One rather extraordinary method for delivery of 442 intracellular antigens to lymphoid inductive sites is through outright lysis of the carrier vaccine to 443 release cytoplasmic contents including foreign proteins (depicted schematically in Figure 2C ).
444
Success with this approach will depend on the timing of lysis, which must occur as vaccine 
472
vaccine organisms were detected in host tissues after three weeks, demonstrating that these engineered strains were able to proliferate long enough to stimulate humoral immunity but were 474 eventually completely cleared from the vaccinated host [53] . This last point may have relevance
475
to previous clinical trials in which orally administered S. Typhimurium WT05 vaccine strains 476 proved unacceptably attenuated and were shed for greater than three weeks from vaccinees [7] .
477
The development of the delayed lysis strategy for carrier vaccines paves the way for 
482
immune responses has now been reported by Kong et al. [57] . In addition to the delayed lysis 
493
Typhimurium carrier vaccine, induced complete protection in orally immunized mice against a 494 lethal intranasal challenge with 100 LD50s of fully virulent influenza virus [57] . Given that DNA 
520
flagellin monomers were exported into the surrounding medium and could be efficiently purified 521 away from intact bacteria. When evaluated in mice, Simon et al. [59] 
535
This approach was used in mouse models of breast cancer [61] and T-cell lymphoma [62] , and 545 [62] . Interestingly, although the attenuated vaccine strain was engineered to be dependent on 546 guanine for growth, viable organisms were recovered from tumor tissues for up to 7 days after 547 injection in both studies; it was hypothesized that a nutrient-rich environment required by a 548 rapidly growing tumor might provide just enough benefit to vaccine organisms to enhance 549 persistence, which could theoretically enhance antitumor inflammatory responses and promote 550 tumor-specific cytotoxicity either directly or indirectly.
In addition to therapeutic interventions, work has also progressed in the development of 552 
588
We believe that with the availability of sufficient genomic data and armed with relevant data on 
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Immunization is represented as a black arrow extending across a vertical black line labeled 
